A Weight Maintenance Program Promoting Fat Loss in Pregnancy in Women With Obesity

Last updated: November 25, 2025
Sponsor: Pennington Biomedical Research Center
Overall Status: Completed

Phase

N/A

Condition

Obesity

Diabetes Prevention

Treatment

Weight Maintenance Group

Clinical Study ID

NCT04731688
PBRC 2019-070
1R01DK124806-01
  • Ages 18-45
  • Female
  • Accepts Healthy Volunteers

Study Summary

The aims of this randomized controlled trial are to determine the effects of a lifestyle program that supports weight maintenance and fat mass loss during pregnancy in women with obesity on changes in 1) maternal weight, fat mass, and cardiometabolic risk factors; 2) safety measures, including fetal and neonatal growth; 3) the mediators and moderators of the fat mass loss intervention and 4) the effects gestational fat mass loss has on reducing incidence of adverse obstetrical outcomes, including non-elective cesarean delivery, gestational diabetes, hypertension, and pre-eclampsia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Are pregnant less than or equal to 15 weeks gestation at screening

  • Have a body mass index between 31.0 and 55.0 inclusive

  • Have a confirmed viable singleton gestation

  • Willing to receive randomization to either group

  • Willing and able to eat the study foods

  • Willing to enroll infant for study measurements after birth

  • Receive clearance from the prenatal care provider for participation

Exclusion

Exclusion Criteria:

  • Smoking, drug, or alcohol use

  • Have a known fetal anomaly

  • Have a non-pregnancy related illness

  • Have pre-existing diabetes

  • Have pre-existing hypertension

  • Have severe anemia

  • Have current mental health issue or eating disorder

  • Short inter-pregnancy interval (<6 months since last pregnancy)

  • Use of assisted reproductive technology

  • Use of medications with known effects on body weight including over the countermedications and supplements for weight loss

  • History of pre-eclampsia, prior small for gestational age infant, bariatric surgery

  • Planning to move out of the area in the next 12 months

Study Design

Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Weight Maintenance Group
Phase:
Study Start date:
March 10, 2021
Estimated Completion Date:
November 24, 2025

Study Description

One hundred pregnant women with obesity who are otherwise healthy will be studied from early pregnancy until approximately 2 weeks postpartum. Major assessments will occur at baseline (13-16 weeks gestation), 27-29 weeks gestation, 35-37 weeks gestation, and approximately 2 weeks postpartum. Safety assessments will be collected every 4 weeks after enrollment. Participants will be randomized within site (approximately 50 individuals at Pennington Biomedical Research Center and approximately 50 individuals at California Polytechnic University) and obesity to either: Provider Directed Group or Weight Maintenance Group.

Connect with a study center

  • California Polytechnic State University

    San Luis Obispo, California 93407
    United States

    Site Not Available

  • California Polytechnic State University

    San Luis Obispo 5392323, California 5332921 93407
    United States

    Site Not Available

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana 70808
    United States

    Site Not Available

  • Pennington Biomedical Research Center

    Baton Rouge 4315588, Louisiana 4331987 70808
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.